- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01714583
The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With Acute Respiratory Distress Syndrome (ARDS) Managed on a Fluid Protocol
The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With ARDS Managed on a Fluid Protocol: A Secondary Analysis of a Prospective Trial
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Yale University, School of Medicine, Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Acute lung injury diagnosis (as defined by The American - European Consensus Conference on ARDS) of < 48 hours in duration.
Patients in the Pulmonary Artery catheter (PAC) arm of the FACTT study. PaO2 / FiO2 ratio of < 200. Data from the first 3 days of mechanical ventilation.
Exclusion Criteria:
Select chronic conditions that could independently influence survival (e.g., expected 6-month survival < 50%) and / or ventilator weaning.
PEEP values missing. FiO2 values missing. PaO2 values missing. Cardiac index values missing Pressors and / or inotropes requirement.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
High PEEP
Cohort of participants with positive end-expiratory pressure (PEEP) greater than or equal to 12cm.
|
|
Low PEEP
Cohort of participants with positive end-expiratory pressure (PEEP) less than 12cm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac Index
Time Frame: Cross sectional (i.e. at time Zero only)
|
The cardiac index is a cardiodynamic measure based on the cardiac output, which is the amount of blood the left ventricle ejects into the systemic circulation in one minute, measured in liters per minute (l/min). Cardiac output is indexed to a patient's body size by dividing by the body surface area to yield the cardiac index. The cardiac index which is the outcome measure is assessed at the same time as the PEEP (which is the independent variable) is measured. The study participants are NOT followed for any period of time. This is a cross-sectional study design. Both variables (Cardiac index and PEEP) are measured at the same time. |
Cross sectional (i.e. at time Zero only)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Wassim H Fares, MD MSc, Yale University, School of Medicine, Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NHLBI T32 HL007106-34
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Distress Syndrome (ARDS)
-
Southeast University, ChinaJiangsu Province Hospital of Traditional Chinese Medicine; The First Affiliated... and other collaboratorsNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Zhongda HospitalRecruitingAcute Respiratory Distress Syndrome (ARDS)China
-
Assistance Publique - Hôpitaux de ParisRecruitingAcute Respiratory Distress Syndrome (ARDS)France
-
EnliTISA (Shanghai) Pharmaceutical Co., Ltd.CompletedAcute Respiratory Distress Syndrome (ARDS)China
-
New York UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Fundacion del Hospital Nacional de Paraplejicos...Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)Spain
-
Jee Hwan AhnNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)South Korea
-
Fayoum UniversityNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Ain Shams UniversityRecruitingAcute Respiratory Distress Syndrome (ARDS)Egypt